Reassessing the role of the p.(Arg304Gln) missense <i>AIP</i> variant in pituitary tumorigenesis

Evidence suggests that R304Q is not pathogenic for pituitary neuroendocrine tumour. We recommend changing this variant classification to likely benign and do not recommend pre-symptomatic genetic testing of family members or follow-up of already identified unaffected individuals with the R304Q variant.

Authors

Institutions

Publication Details

Journal
European Journal of Endocrinology
Published
2025-03-12
DOI
https://doi.org/10.1093/ejendo/lvaf044
Citations
1
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
1.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis

Jakob Dal, Bernard Chong Eu Khoo, Tobias Else, Mariana Bizzi et al.
1 citations
European Journal of Endocrinology
Genomics and Rare Diseases
1.82
article

Reassessing the role of the p.(Arg304Gln) missense AIP variant in pituitary tumorigenesis

Jakob Dal, Bernard Chong Eu Khoo, Tobias Else, Mariana Bizzi, Christof Schöfl, Antônio Ribeiro‐Oliveira, Márta Korbonits, Paul Benjamin Loughrey, Matheus de Oliveira Andrade, Anne Barlier, Mark D. Ludman, Louise Metherell, Gianluca Occhi, Daniel Flanagan, Philippe Chanson, Giorgio Arnaldi, Marianne S. Elston, Serban Radian, Mary Dang, Sérgio Veloso Brant Pinheiro, Simona Fica, Francesco Ferraù, Mônica R. Gadelha, Nadira B Mothojakan, Ionela Pașcanu, Donato Iacovazzo, Alessia David, Elena Daniela Aflorei, Laura C. Hernández‐Ramírez, Sonal Kapur, Ajith Kumar, Albert Beckers, Ronald M. Lechan, Martina Owens, Kashyap Patel, Adrian Daly, Ankit M Arni, Chandan Kumar‐Sinha, Dragana Miljić, Amy Evans, Mädälina Muşat, Vishnou Mourougavelou
article en
1 citations

Abstract

Evidence suggests that R304Q is not pathogenic for pituitary neuroendocrine tumour. We recommend changing this variant classification to likely benign and do not recommend pre-symptomatic genetic testing of family members or follow-up of already identified unaffected individuals with the R304Q variant.

European Journal of EndocrinologyVol. 192(4)
Universidade Federal de Minas Gerais (BR), University of Messina (IT), Universidade Federal do Rio de Janeiro (BR), Queen's University Belfast (GB), Tufts Medical Center (US), University of Padua (IT), Universidade de Brasília (BR), University of Auckland (NZ), Inserm (FR), Carol Davila University of Medicine and Pharmacy (RO), Queen Mary University of London (GB), Aix-Marseille Université (FR), University of Exeter (GB), Université Paris-Saclay (FR), Royal Devon & Exeter NHS Foundation Trust (GB), Aalborg University Hospital (DK), Great Ormond Street Hospital (GB), The Royal Free Hospital (GB), Meir Medical Center (IL), Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO), University of Belgrade (RS), Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (MX), Emergency University (US), Bamberg County Hospital (US), Michigan Medicine (US), Michigan Center for Translational Pathology (US), Clinical Trials New Zealand (NZ), NIHR Exeter Clinical Research Facility (GB), University Clinical Centre (PL), Centre Hospitalier Universitaire de Liège (BE), University of Palermo (AR), Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT), Sozialstiftung Bamberg (DE), Hôpital de la Timone (FR), Bicêtre Hospital (FR), University Hospitals Plymouth NHS Trust (GB), University College London (GB), Imperial College London (GB), University of Waikato (NZ), Universidade Federal do Estado do Rio de Janeiro (BR), Aalborg University (DK), University of Bamberg (DE)
New York State Department of Health, University of Michigan, Wellcome Trust, Barts Charity, National Institute for Health and Care Research, Rosetrees Trust, Public Health Agency, Medical Research Centre, Pfizer UK, Medical Research Council
Openalex Percentile: Top 18%
Genomics and Rare Diseases
1.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.